Researchers from Children's Hospital of Philadelphia (CHOP) have found that dysfunction in an important cell subtype in the brain's neuronal network contribute to chronic symptoms in the neurodevelopmental disorder Dravet ...
Mar 29, 2022
0
48
Aalto University doctoral candidate Dennis Yeung and his research group have developed and tested a new type of technology that enables better compatibility between a prosthesis and the amputated area. The study was conducted ...
Mar 18, 2022
0
75
Different diseases have different methods for testing if a person has the disease or not. immuneML, a new open source machine learning platform, can potentially look for a lot of diseases in just one blood sample.
Jan 26, 2022
0
44
When we talk about antibodies against COVID-19, we tend to mean the so-called neutralizing antibodies, that offer protection by blocking the virus from invading our cells. Now, a new study from Lund University in Sweden has ...
Jan 17, 2022
0
231
Using a stem-cell-derived model, researchers have identified two drug candidates that may slow dry age-related macular degeneration (AMD), a leading cause of blindness for which no treatment exists. The scientists, from the ...
Dec 15, 2021
0
54
Psychology researchers at North Carolina State University have developed and validated a new tool for assessing how accurate people are at recognizing emotion in elementary school-aged children. The technique will facilitate ...
Nov 2, 2021
0
42
Autoimmune diseases—i.e. diseases where our own immune system damages the body—are growing, but we know little about what triggers them.
Oct 15, 2021
0
127
MIT engineers, in collaboration with scientists at Cancer Research UK Manchester Institute, have developed a new way to grow tiny replicas of the pancreas, using either healthy or cancerous pancreatic cells. Their new models ...
Sep 13, 2021
0
125
Lung cancer remains the leading cause of cancer-associated death in the United States and worldwide. Patients with a subtype called lung adenocarcinoma (LUAD) have benefited from the development of new targeted medicines, ...
Aug 5, 2021
0
238
The Biomedical Genomics laboratory at IRB Barcelona has developed a computational tool that identifies cancer driver mutations for each tumor type.
Jul 29, 2021
0
159
